Work

15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients

Year: 2020

Type: article

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2020-igcs.15

Authors: R. Rocconi, E. Grosen, S. Ghamande, J. Chan, M. Barve, J. Oh, D. Tewari, P. Morris, E. Stevens, J. Bottsford-Miller, M. Tang, P. Aaron, G. Wallraven, E. Bognar, L. Manning, J. Nemunaitis, B. Slomovitz, T. Herzog, B. Monk, R. Coleman

Institutions: USA Mitchell Cancer Institute, University of South Alabama, Cancer Care Northwest, Augusta University, California Pacific Medical Center, Mary Crowley Cancer Research Center, Texas Oncology, Kaiser Permanente, Billings Clinic, Gradalis (United States), University of Miami, Sylvester Comprehensive Cancer Center, University of Cincinnati, University of Cincinnati Medical Center, Arizona Oncology, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3103449189

FWCI: 0.181

Cites:

Cited by: 1

Related to: 10